Neema Jamshidi, MD, PhD
Specialty
Institutional Affiliation
Languages
Education
Fellowship
Internship
Degrees
Residency
Board Certification
Contact Information
Phone
Scientific Interests
Dr. Neema Jamshidi's research uses multi-resolution, state-of-the-art imaging technologies spanning cellular, omic-profile and clinical cross-sectional imaging to construct predictive models of biological processes in order to understand how malignant transformations occur and how to intervene/block these processes.
Highlighted Publications
Jamshidi N, Huang D, Abtin FG, Loh CT, Kee ST, Suh RD, Yamamoto S, Das K, Dry S, Binder S, Enzmann DR, Kuo MD. Genomic Adequacy from Solid Tumor Core Needle Biopsies of ex Vivo Tissue and in Vivo Lung Masses: Prospective Study. Radiology. 2017 Mar;282(3):903-912. doi: 10.1148/radiol.2016132230. Epub 2016 Oct 18.
Zielinski DC, Jamshidi N, Corbett AJ, Bordbar A, Thomas A, Palsson BO. Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism. Sci Rep. 2017 Jan 25;7:41241. doi: 10.1038/srep41241.
Jamshidi N, Margolis DJ, Raman S, Huang J, Reiter RE, Kuo MD. Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma. Radiology. 2017 Jul;284(1):109-119. doi: 10.1148/radiol.2017162827. Epub 2017 Apr 28.
Du L, Yamamoto S, Burnette BL, Huang D, Gao K, Jamshidi N, Kuo MD. Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFBeta-induced epithelial-to-mesenchymal transition. Cancer Med. 2016 Aug;5(8):1962-72. doi: 10.1002/cam4.719. Epub 2016 Jun 18.
Jamshidi N, Jonasch E, Zapala M, Korn RL, Aganovic L, Zhao H, Tumkur Sitaram R, Tibshirani RJ, Banerjee S, Brooks JD, Ljungberg B, Kuo MD. The Radiogenomic Risk Score: Construction of a Prognostic Quantitative, Noninvasive Image-based Molecular Assay for Renal Cell Carcinoma. Radiology. 2015 Oct;277(1):114-23. doi: 10.1148/radiol.2015150800. Epub 2015 Aug 19.